HOME >> BIOLOGY >> NEWS
Schepens Eye Research Institute receives 'Roadmap' grant to develop center for curing eye diseases

Boston, Mass The Schepens Eye Research Institute has been awarded a grant from the National Institutes of Health to form teams of basic and clinical researchers from many disciplines to find cures for blinding eye diseases such as macular degeneration, diabetic retinopathy and glaucoma. The Institute competed with hundreds of organizations for the award. It is the only eye research institute to receive this type of award. The grant is part of a larger initiative known as the "NIH Roadmap," which seeks to find new ways to solve problems that have not yielded to traditional research. NIH is announcing the recipients of these special awards today in Bethesda.

"This is an exciting opportunity to bring enormous energy and new brain power to solve some of the most complex puzzles in eye research," says Darlene Dartt, PhD, the Director of Scientific Affairs at Schepens who is heading up the project. The Institute plans to combine forces with Massachusetts Eye and Ear Infirmary, Harvard Medical School and other Harvard teaching hospitals by enlisting top investigators exploring diseases as diverse as Alzheimer's, rheumatoid arthritis and heart disease to be part of a "think tank" to cure blindness.

As the population ages, the need for new treatments for vision-robbing diseases is becoming critical. Age-related macular degeneration affects more than 1.75 million individuals in the United States. This number is expected to increase to almost 3 million by 2020.Each year 1.3 million Americans over age 20 are diagnosed with diabetic retinopathy. The financial impact and effect on quality of life for people diagnosed with one of these disorders is devastating, says Dartt.

Eye diseases share many of the same underlying mechanisms at work in diseases in other parts of the body, like the heart and the brain. "While experts from these areas often collaborate informally on vision disease, ophthalmology has remained somewhat specialized and in some ways isola
'"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
617-872-0364
Schepens Eye Research Institute
30-Sep-2004


Page: 1 2 3

Related biology news :

1. Schepens Eye Research Institute scientists at ARVO
2. Obesity gene causes cancer of fat tissue, Schepens scientists find
3. Researchers determine genetic cause of Timothy syndrome
4. Researchers find color sensitive atomic switch in bacteria
5. Researchers identify protein promoting vascular tumor growth
6. Researchers devise potent new tools to curb ivory poaching
7. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
8. Researchers ID chlorophyll-regulating gene
9. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
10. Research suggests new avenue for stopping, preventing colon cancer
11. Researchers develop fast track way to discover how cells are regulated

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in ... 8:30aET on RFD-TV. , With global population estimates nearing ten billion people by ... feed a growing nation. At the same time, many of our valuable resources are ...
(Date:10/7/2017)... WA (PRWEB) , ... October ... ... industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution ... ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome ...
Breaking Biology Technology:
Cached News: